June 16, 2021
2 mins read

‘Pfizer, AZ jabs highly effective against Delta variant’

These are comparable with vaccine effectiveness against hospitalisation from the Alpha (B117) variant: 96 per cent after two doses with Pfizer vaccine and 92 per cent after two doses from AstraZeneca vaccines…reports Asian Lite News.

Two doses of Pfizer and AstraZeneca’s Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to new analysis from Public Health England (PHE).

The analysis suggests that the Pfizer-BioNTech vaccine is 96 per cent effective against hospitalisation after two doses, while the Oxford-AstraZeneca vaccine is 92 per cent effective against hospitalisation after two doses.

These are comparable with vaccine effectiveness against hospitalisation from the Alpha (B117) variant: 96 per cent after two doses with Pfizer vaccine and 92 per cent after two doses from AstraZeneca vaccines.

The new analysis included 14,019 cases of the Delta variant, 166 of whom were hospitalised between 12 April and 4 June, looking at emergency hospital admissions in England. The results have been posted as a preprint. Preprints are yet to be peer-reviewed.

“This evidence of the effectiveness of two doses against variants shows just how crucial it is to get your second jab. If you have had your first dose but haven’t booked your second yet — please do so. It will help save lives and boost us on the road to recovery,” said Health and Social Care Secretary Matt Hancock, in a statement.

“These hugely important findings confirm that the vaccines offer significant protection against hospitalisation from the Delta variant. The vaccines are the most important tool we have against Covid-19. Thousands of lives have already been saved because of them. It is absolutely vital to get both doses as soon as they are offered to you, to gain maximum protection against all existing and emerging variants,” added Dr Mary Ramsay, Head of Immunisation at PHE.

A study by PHE in May showed that three weeks after the first dose of both Pfizer and AstraZeneca’s coronavirus vaccine provided only 33 per cent protection against the Delta variant, while it offered 50 per cent effectiveness against the Alpha variant.

The B16172 variant was first discovered in India and is one of three related strains. It was declared as a variant of global concern last month by the World Health Organization (WHO). It is 60 per cent more transmissible than the Alpha strain identified in the UK.

ALSO READ-‘Delta Plus ‘variant of interest’ for now’

READ MORE-‘Delta’ Variant 40% More Contagious

Previous Story

Covid jabs to become mandatory for care home staff

Next Story

135 Indian peacekeepers honoured with UN medals

Latest from -Top News

Pakistan may face stricter IMF terms

The International Monetary Fund (IMF) will undertake its next funding review for Pakistan in the second half of 2025, with 11 new conditions now attached to the continuation of its Extended Fund

Indian diaspora in Japan backs Operation Sindoor

Members of the Indian diaspora in Japan have strongly endorsed Operation Sindoor, India’s targeted military response to the April 22 terror attack in Pahalgam, Kashmir, praising Prime Minister Narendra Modi’s leadership and

What Sri Lanka Can Learn from Pahalgam

If Sri Lanka’s support for India in combating terrorism is genuine, how can Pakistan—widely accused of using terrorism as a tool against India—be treated as an equal partner….writes A. Jathindra While references
Go toTop

Don't Miss

Bangladesh to buy Chinese vaccines

Earlier, the country had received seven million Covishield doses through

Sonu :Vaccine should be be free

Sonu’s tweet came in reaction to a news piece that